{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:56:39Z","timestamp":1791219399645,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":95,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Bengbu Medical University","award":["2023byzd057"],"award-info":[{"award-number":["2023byzd057"]}]},{"name":"Office of Science and Technology of Anhui Province","award":["202427b10020073"],"award-info":[{"award-number":["202427b10020073"]}]},{"name":"Office of Science and Technology of Anhui Province","award":["202427b10020073"],"award-info":[{"award-number":["202427b10020073"]}]},{"name":"Office of Science and Technology of Anhui Province","award":["202427b10020073"],"award-info":[{"award-number":["202427b10020073"]}]},{"name":"Office of Science and Technology of Anhui Province","award":["202427b10020073"],"award-info":[{"award-number":["202427b10020073"]}]},{"name":"Office of Science and Technology of Anhui Province","award":["202427b10020073"],"award-info":[{"award-number":["202427b10020073"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03228-9","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T22:54:12Z","timestamp":1782428052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HPV epidemiologic study in Bengbu, China, involving 123,808 women, 2014\u20132023"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaowen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manman","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"3228_CR1","unstructured":"Bruni L, Albero G, Serrano B, Mena M, Collado JJ, G\u00f3mez D et al. Human papillomavirus and related diseases world summary report. Lyon, France: International Agency for Research on Cancer\/Institut Catal\u00e0 d\u2019Oncologia (IARC\/ICO); 2023 [cited 2025 May 22]. Available from: https:\/\/hpvcentre.net\/statistics\/reports\/XWX.pdf"},{"key":"3228_CR2","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem [Internet]. Geneva: World Health Organization. 2020 [cited 2025 May 22]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240014107"},{"key":"3228_CR3","first-page":"1","volume":"90","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2007","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2007;90:1\u2013636.","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"3228_CR4","unstructured":"Chinese Preventive Medicine Association, Branch of Vaccines and Immunization, Wang HQ, Zhao FH et al. Expert consensus on immunization for the prevention of cervical cancer and other human papillomavirus-related diseases. Chin J Prev Med. 2019;53(8):761\u2013803."},{"key":"3228_CR5","doi-asserted-by":"crossref","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical Cancer. The Lancet [Internet]. 2019;393(10167):169\u201382. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30638582\/","DOI":"10.1016\/S0140-6736(18)32470-X"},{"issue":"5","key":"3228_CR6","first-page":"570","volume":"27","author":"YF Song","year":"2021","unstructured":"Song YF, Liu XX, Yin ZD, et al. Estimated HPV vaccination coverage among Chinese females aged 9\u201345 years from 2018 to 2020. Chin J Vaccines Immun. 2021;27(5):570\u20135.","journal-title":"Chin J Vaccines Immun"},{"key":"3228_CR7","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. World Health Organization; 2024."},{"key":"3228_CR8","unstructured":"National Health Commission of the People\u2019s Republic of China. Guidelines for diagnosis and treatment of cervical cancer (2022 edition) [Internet]. Beijing: National Health Commission of the People\u2019s Republic of China; 2022 [cited 2025 May 22]. Available from: http:\/\/www.nhc.gov.cn\/cms-search\/downFiles\/361f086b71214c4e8336fa7d251dc020.pdf"},{"issue":"4","key":"3228_CR9","first-page":"241","volume":"40","author":"XY Gu","year":"2018","unstructured":"Gu XY, Zheng RS, Sun KX, et al. Incidence and mortality of cervical cancer among Chinese women in 2014. Zhonghua Zhong Liu Za Zhi. 2018;40(4):241\u20136.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"3228_CR10","doi-asserted-by":"publisher","unstructured":"Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30 Suppl 5:F12-23. https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.055. PMID: 23199955.","DOI":"10.1016\/j.vaccine.2012.07.055"},{"issue":"11","key":"3228_CR11","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1002\/cam4.2017","volume":"8","author":"B Zhu","year":"2019","unstructured":"Zhu B, Liu Y, Zuo T, Cui X, Li M, Zhang J, et al. The prevalence, trends, and geographical distribution of human papillomavirus infection in China: The pooled analysis of 1.7 million women. Cancer Med. 2019;8(11):5373\u201385.","journal-title":"Cancer Med"},{"issue":"7","key":"3228_CR12","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/cncr.32003","volume":"125","author":"K Li","year":"2019","unstructured":"Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019;125(7):1030\u20137.","journal-title":"Cancer"},{"key":"3228_CR13","doi-asserted-by":"publisher","unstructured":"Wang T, Luan L, Deng J, Liu N, Wu Q, Gong T et al. Prevalence and human papillomavirus (HPV) genotype distribution in Suzhou, China. Hum Vaccines Immunotherapeutics. 2023;19(2):2241309-2241309. https:\/\/doi.org\/10.1080\/21645515.2023.2241309","DOI":"10.1080\/21645515.2023.2241309"},{"key":"3228_CR14","unstructured":"ICO\/IARC Information Centre on HPV and Cancer. Human papillomavirus and related diseases in China [Internet]. 2023 Mar 10 [cited 2026 Jan 27]. Available from: https:\/\/hpvcentre.net\/"},{"key":"3228_CR15","doi-asserted-by":"crossref","unstructured":"Wang J, Tang D, Wang K, Wang J, Zhang Z, Chen Y et al. HPV genotype prevalence and distribution during 2009\u20132018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. BMC Women\u2019s Health. 2019;19(1):2241309\u20132241309.","DOI":"10.1186\/s12905-019-0785-3"},{"issue":"7","key":"3228_CR16","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/jmv.24029","volume":"87","author":"H Xue","year":"2015","unstructured":"Xue H, Lin X, Li T, Yan X, Guo K, Zhang Y. Prevalence and genotype distribution of human papillomavirus infection in asymptomatic women in Liaoning province, China. J Med Virol. 2015;87(7):1248\u201353.","journal-title":"J Med Virol"},{"key":"3228_CR17","doi-asserted-by":"crossref","unstructured":"Yao X, Li Q, Chen Y, Du Z, Huang Y, Zhou Y et al. Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023. Front Public Health. 2024;12:1332696\u20131332696.","DOI":"10.3389\/fpubh.2024.1332696"},{"key":"3228_CR18","doi-asserted-by":"crossref","unstructured":"Wang J, Li H, Zhang J, Wang H, Li Y, Liu Z et al. Epidemiology and genotypes analysis of human papillomavirus infection in Beijing, China. Virol J. 2024;21(1):19\u201319.","DOI":"10.1186\/s12985-024-02292-3"},{"issue":"6","key":"3228_CR19","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/jmv.27498","volume":"94","author":"X Wei","year":"2021","unstructured":"Wei X, Lu Q, Wang S. Prevalence characteristics of cervical human papillomavirus genotypes in Nanning, China: A 10-year survey of 77,756 women from one medical center. J Med Virol. 2021;94(6):2787\u201395.","journal-title":"J Med Virol"},{"issue":"1","key":"3228_CR20","doi-asserted-by":"publisher","first-page":"e2176009","DOI":"10.1080\/22221751.2023.2176009","volume":"12","author":"X Yang","year":"2023","unstructured":"Yang X, Li Y, Tang Y, Li Z, Wang S, Luo X, et al. Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021. Emerg Microbes Infections [Internet]. 2023;12(1):e2176009.","journal-title":"Emerg Microbes Infections [Internet]"},{"key":"3228_CR21","doi-asserted-by":"crossref","unstructured":"Yan X, Shen L, Xiao Y, Wang Q, Li F, Qian Y. Prevalence, characteristics, and distribution of HPV genotypes in women from Zhejiang Province, 2016\u20132020. Virol J. 2021;18(1):208\u2013208.","DOI":"10.1186\/s12985-021-01676-z"},{"issue":"12","key":"3228_CR22","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1002\/jmv.25899","volume":"92","author":"J Liu","year":"2020","unstructured":"Liu J, Shi Y, Wang L, Wang J, Fan D, Han S, et al. Epidemiology and persistence of cervical human papillomavirus infection among outpatient women in Heilongjiang province: A retrospective cohort study. J Med Virol. 2020;92(12):3784\u201392.","journal-title":"J Med Virol"},{"key":"3228_CR23","doi-asserted-by":"crossref","unstructured":"Jiang L, Tian X, Peng D, Zhang L, Xie F, Bi C et al. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong\u2019s largest independent pathology laboratory. Qu F, editor. PLOS ONE. 2019;14(1):e0210311.","DOI":"10.1371\/journal.pone.0210311"},{"key":"3228_CR24","doi-asserted-by":"crossref","unstructured":"Pujolar G, Oliver-Angl\u00e8s A, Vargas I, V\u00e1zquez ML. Changes in Access to Health Services during the COVID-19 Pandemic: A Scoping Review. International Journal of Environmental Research and Public Health [Internet]. 2022;19(3):1749. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8834942\/","DOI":"10.3390\/ijerph19031749"},{"issue":"7","key":"3228_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S de Sanjos\u00e9","year":"2007","unstructured":"de Sanjos\u00e9 S, Diaz M, Castellsagu\u00e9 X, Clifford G, Bruni L, Mu\u00f1oz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453\u20139.","journal-title":"Lancet Infect Dis"},{"key":"3228_CR26","unstructured":"National Health Commission of the People\u2019s Republic of China. Interpretation of the \u2018Action Plan for Accelerating the Elimination of Cervical Cancer (2023\u20132030)\u2019. [Internet]. Beijing: National Health Commission of the People\u2019s Republic of China; 2023 Jan 21 [cited 2023 Oct 1]. Available from: https:\/\/www.gov.cn\/zhengce\/2023-01\/21\/content_5738365.htm"},{"issue":"1","key":"3228_CR27","doi-asserted-by":"publisher","first-page":"2329450","DOI":"10.1080\/21645515.2024.2329450","volume":"20","author":"C Zhao","year":"2024","unstructured":"Zhao C, Zhao Y, Li J, Li M, Shi Y, Wei L. Opportunities and challenges for human papillomavirus vaccination in China. Hum Vaccin Immunother. 2024;20(1):2329450. https:\/\/doi.org\/10.1080\/21645515.2024.2329450.","journal-title":"Hum Vaccin Immunother"},{"key":"3228_CR28","doi-asserted-by":"publisher","first-page":"820517","DOI":"10.3389\/fpubh.2022.820517","volume":"10","author":"EL Wong","year":"2022","unstructured":"Wong EL, Cheung AW, Chen Z, Wong AY, Yeung AC, Yau PS, et al. Molecular epidemiology of human papillomavirus infection among Chinese women with cervical cytological abnormalities. Front Public Health. 2022;10:820517.","journal-title":"Front Public Health"},{"key":"3228_CR29","unstructured":"ICO\/IARC Information Centre on HPV and Cancer. Human papillomavirus and related diseases in the world. Summary report 2023. [Internet]. Barcelona: ICO\/IARC Information Centre on HPV and Cancer; 2023 [cited 2026-01-25]. Available from: https:\/\/hpvcentre.net\/"},{"issue":"1","key":"3228_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12879-021-06019-5","volume":"21","author":"LP Luo","year":"2021","unstructured":"Luo LP, He P, Liu QT, Jiang YH, Zhang YN, Li QZ, Li Q, Li ST, Yang F, Ling H, Dai XG, Li ZY, Chen HL. Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012\u20132018: baseline measures prior to mass HPV vaccination. BMC Infect Dis. 2021;21(1):328. https:\/\/doi.org\/10.1186\/s12879-021-06019-5.","journal-title":"BMC Infect Dis"},{"key":"3228_CR31","doi-asserted-by":"crossref","unstructured":"Rizzo A, Davide Moschese, Salari F, Giacomelli A, Morelli L, Cossu MV et al. High prevalence of high-risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy. J Med Virol. 2024;96(1):e29370.","DOI":"10.1002\/jmv.29370"},{"key":"3228_CR32","doi-asserted-by":"publisher","unstructured":"Chan PK, Ho WC, Chan MC, Wong MC, Yeung AC, Chor JS et al. Meta-analysis on prevalence and attribution of human papillomavirus types 52 and58 in cervical neoplasia worldwide[J]. PLoS One.2014; 9: e107573. https:\/\/doi.org\/10.1371\/journal.pone.0107573 PMID: 25229350.","DOI":"10.1371\/journal.pone.0107573"},{"issue":"2","key":"3228_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0304-3835(03)00312-4","volume":"198","author":"SA Lee","year":"2003","unstructured":"Lee SA, Kang D, Seo SS, Jeong JK, Yoo KY, Jeon YT, et al. Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer Lett. 2003;198(2):187\u201392.","journal-title":"Cancer Lett"},{"key":"3228_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ygyno.2008.12.037","volume":"113","author":"A Spinillo","year":"2009","unstructured":"Spinillo A, Bello BD, Gardella B, Roccio M, Dacco MD, Silini EM, et al. Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined signifificance or low grade squamous intraepithelial lesions. Gynecol Oncol. 2009;113:115\u20139.","journal-title":"Gynecol Oncol"},{"key":"3228_CR35","doi-asserted-by":"publisher","unstructured":"Serrano B, Alemany L, Ruiz PA, Tous S, Lima MA, Bruni L et al. Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China). Cancer Epidemiol. 2014; 38: 748\u2013756. https:\/\/doi.org\/10.1016\/j.canep.2014.09.003 PMID: 25305098.","DOI":"10.1016\/j.canep.2014.09.003"},{"issue":"2","key":"3228_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/jmv.21382","volume":"81","author":"MT Sandri","year":"2009","unstructured":"Sandri MT, Riggio D, Michela Salvatici, Passerini R, Zorzino L, Boveri S, et al. Typing of human papillomavirus in women with cervical lesions: Prevalence and distribution of different genotypes. J Med Virol. 2009;81(2):271\u20137.","journal-title":"J Med Virol"},{"issue":"7","key":"3228_CR37","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1086\/597308","volume":"199","author":"R Herrero","year":"2009","unstructured":"Herrero R. Human Papillomavirus (HPV) Vaccines: Limited Cross-Protection against Additional HPV Types. J Infect Dis. 2009;199(7):919\u201322.","journal-title":"J Infect Dis"},{"key":"3228_CR38","doi-asserted-by":"crossref","unstructured":"Li X, Xiang F, Dai J, Zhang T, Chen Z, Zhang M et al. Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China. Virol J. 2022;19(1):146\u2013146.","DOI":"10.1186\/s12985-022-01879-y"},{"issue":"3","key":"3228_CR39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.vaccine.2018.11.075","volume":"37","author":"JM Brotherton","year":"2019","unstructured":"Brotherton JM, Hawkes D, Sultana F, Malloy MJ, Machalek DA, Smith MA, et al. Age-specific HPV prevalence among 116,052 women in Australia\u2019s renewed cervical screening program: a new tool for monitoring vaccine impact. Vaccine. 2019;37(3):412\u20136.","journal-title":"Vaccine"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03228-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03228-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03228-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:05:45Z","timestamp":1790676345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-026-03228-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3228"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03228-9","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research involving humans was approved by the Ethics Committee of Bengbu Medical University(Approval No. BMU-IRB-2024-418). The study was conducted in accordance with local laws and institutional requirements. Because of the retrospective nature of the study, patients were not required to submit written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. (This study utilized anonymized epidemiological data with no personally identifiable information.)","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"227"}}